Hope for Brain Cancer: ¼ø»Æʦapp Awarded Grants for Glioblastoma Treatment
¼ø»Æʦapp researchers are pioneering a new approach to treating glioblastoma - a highly aggressive brain cancer with one of the highest mortality rates - by targeting the gene MBLAC1 for the first time.
¼ø»Æʦapp Gets $1M to Prevent Medication-related Harm, Falls in Older Adults
¼ø»Æʦapp Schmidt College of Medicine researchers will develop a targeted approach to eliminate the guesswork in medication management to reduce the risk of adverse drug events - particularly dangerous falls.
¼ø»Æʦapp Hosts Second Annual FairfaxWood Amyloid Related Diseases Summit
¼ø»Æʦapp's Charles E. Schmidt College of Medicine recently hosted the summit, bringing together top scientists from North America and Europe to discuss the latest amyloid research and advancements.
'Eye' on Health: AI Detects Dizziness and Balance Disorders Remotely
¼ø»Æʦapp researchers and collaborators have developed a cost-effective, AI-powered system for diagnosing nystagmus - a condition causing involuntary eye movements - using smartphone videos and cloud-based analysis.
Fixing the Leak: An Opioid Treatment for Dopamine Disorders?
A breakthrough by ¼ø»Æʦapp researchers shows that blocking the kappa opioid receptor improves behavioral deficits tied to ADHD, autism and bipolar disorder, providing a potentially safer yet effective treatment.
'Loop'hole: HIV-1 Hijacks Human Immune Cells Using Circular RNAs
¼ø»Æʦapp researchers have identified a never-before-seen mechanism that enables HIV-1 to evade the body's natural defenses and use it to support its survival and replication.
From Students to Physicians: ¼ø»Æʦapp Celebrates Graduating Class of 2025
The Charles E. Schmidt College of Medicine celebrated the nation's newest physicians and biomedical researchers during its commencement ceremony today at the Carole and Barry Kaye Auditorium.
¼ø»Æʦapp Ranks Among 2025 Best Graduate Schools in U.S. News
¼ø»Æʦapp has been ranked among the 2025 Best Graduate Schools by U.S. News & World Report.
Experts Challenge Aspirin Guidelines Based on Flawed Trial Reliance
Experts argue that the flawed results of the ASPREE trial unduly influenced aspirin restrictions, highlighting the need for rigorous statistical principles in trial design to avoid misleading conclusions.
¼ø»Æʦapp Secures $1.3M NIH Grant for HIV Self-Test Technology Breakthrough
¼ø»Æʦapp engineering and biomedical researchers are working to meet a critical global health need by developing a reliable, rapid and affordable HIV test for early detection, with an expected cost of under $5.